$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

$cpix Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000162828024010725 Filed on March 13, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q3
Revenue	$8.498M	$9.353M	$10.09M
YoY Change	-7.88%	2.51%	-11.63%
Cost Of Revenue	$1.576M	$1.530M	$1.766M
YoY Change	26.02%	-65.62%	-20.63%
Gross Profit	$6.922M	$7.823M	$8.320M
YoY Change	-13.19%	67.4%	-9.45%
Gross Profit Margin	81.46%	83.64%	82.49%
Selling, General & Admin	$6.522M	$8.198M	$7.087M
YoY Change	-3.75%	19.04%	12.91%
% of Gross Profit	94.23%	104.8%	85.18%
Research & Development	$1.158M	$1.265M	$1.925M
YoY Change	-22.77%	-10.04%	12.28%
% of Gross Profit	16.73%	16.17%	23.13%
Depreciation & Amortization	$1.151M	$1.233M	$1.246M
YoY Change	-8.36%	141.12%	-19.32%
% of Gross Profit	16.62%	15.76%	14.98%
Operating Expenses	$7.681M	$14.00M	$9.012M
YoY Change	-7.19%	60.01%	12.78%
Operating Profit	-$1.869M	-$6.179M	-$1.867M
YoY Change	22.04%	171.28%	546.81%
Interest Expense	$118.5K	-$97.79K	$110.1K
YoY Change	-36.4%	-26.89%	-26.29%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$821.8K
YoY Change	-100.0%
Pretax Income	-$1.891M	-$6.277M	-$1.056M
YoY Change	-1155.12%	160.29%	153.71%
Income Tax	$11.44K	$24.96K	$6.938K
% Of Pretax Income
Net Earnings	-$1.946M	-$6.294M	-$1.049M
YoY Change	-1112.71%	157.89%	156.78%
Net Earnings / Revenue	-22.9%	-67.3%	-10.4%
Basic Earnings Per Share	-$0.14	-$0.44	-$0.07
Diluted Earnings Per Share	-$0.14	-$0.44	-$0.07
COMMON SHARES
Basic Shares Outstanding	14.18M shares	14.26M shares	14.37M shares
Diluted Shares Outstanding	14.10M shares		14.28M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.55M	$18.32M	$18.51M
YoY Change	13.2%	-7.27%	-5.29%
Cash & Equivalents	$18.55M	$18.32M	$18.51M
Short-Term Investments
Other Short-Term Assets	$2.683M	$3.025M	$1.971M
YoY Change	-1.21%	-1.94%	-47.28%
Inventory	$4.328M	$4.609M	$8.671M
Prepaid Expenses
Receivables	$10.65M	$9.758M	$12.62M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$36.21M	$35.71M	$41.77M
YoY Change	-17.36%	-22.14%	-15.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$369.5K	$7.042M	$377.4K
YoY Change	4.13%	2379.34%	-23.1%
Goodwill	$914.0K	$914.0K	$914.0K
YoY Change	0.0%	0.0%	-52.71%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.061M	$15.50M	$2.556M
YoY Change	20.24%	514.82%	5.3%
Total Long-Term Assets	$45.30M	$46.06M	$45.98M
YoY Change	-0.78%	-2.11%	10.49%
TOTAL ASSETS
Total Short-Term Assets	$36.21M	$35.71M	$41.77M
Total Long-Term Assets	$45.30M	$46.06M	$45.98M
Total Assets	$81.51M	$81.78M	$87.75M
YoY Change	-8.9%	-12.0%	-3.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.08M	$14.04M	$10.82M
YoY Change	16.52%	29.75%	-6.02%
Accrued Expenses	$362.2K	$348.1K	$334.3K
YoY Change	128.73%	-98.02%	45.59%
Deferred Revenue		$220.4K
YoY Change		-64.14%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.43M	$27.98M	$27.33M
YoY Change	2.79%	-2.09%	7.99%
LONG-TERM LIABILITIES
Long-Term Debt	$16.08M	$12.78M	$12.92M
YoY Change	0.07%	-21.09%	-26.99%
Other Long-Term Liabilities	$6.610M	$11.75M	$6.455M
YoY Change	-6.78%	54.91%	-30.43%
Total Long-Term Liabilities	$6.610M	$24.53M	$6.455M
YoY Change	-6.78%	223.45%	-76.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.43M	$27.98M	$27.33M
Total Long-Term Liabilities	$6.610M	$24.53M	$6.455M
Total Liabilities	$54.32M	$52.17M	$52.10M
YoY Change	1.68%	-8.39%	-0.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.43M	-$17.49M	-$11.19M
YoY Change	76.41%	56.02%	27.66%
Common Stock			$47.19M
YoY Change			-0.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.49M	$29.60M	$35.99M
YoY Change
Total Liabilities & Shareholders Equity	$81.51M	$81.78M	$87.75M
YoY Change	-8.9%	-12.0%	-3.33%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.946M	-$6.294M	-$1.049M
YoY Change	-1112.71%	157.89%	156.78%
Depreciation, Depletion And Amortization	$1.151M	$1.233M	$1.246M
YoY Change	-8.36%	141.12%	-19.32%
Cash From Operating Activities	-$2.137M	$1.040M	$1.237M
YoY Change	50.66%	-71.41%	-53.08%
INVESTING ACTIVITIES
Capital Expenditures	$41.62K	$86.72K	$95.07K
YoY Change	-61.2%	-94.71%	-143.5%
Acquisitions
YoY Change
Other Investing Activities		$347.4K	$0.00
YoY Change		-65.26%	-100.0%
Cash From Investing Activities	-$58.19K	$260.6K	-$95.07K
YoY Change	-66.65%	-140.67%	-113.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.422M	-1.487M	-882.6K
YoY Change	-236.12%	-46.52%	-55.67%
NET CHANGE
Cash From Operating Activities	-$2.137M	1.040M	1.237M
Cash From Investing Activities	-$58.19K	260.6K	-95.07K
Cash From Financing Activities	$2.422M	-1.487M	-882.6K
Net Change In Cash	$226.9K	-186.4K	258.9K
YoY Change	-106.73%	-186.11%	-80.46%
FREE CASH FLOW
Cash From Operating Activities	-$2.137M	$1.040M	$1.237M
Capital Expenditures	$41.62K	$86.72K	$95.07K
Free Cash Flow	-$2.178M	$953.4K	$1.141M
YoY Change	42.79%	-52.26%	-60.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Interest Expense InterestExpense	667861	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6284997	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5581189	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68850	usd
CY2023	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	346800	usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001087294
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1765329
CY2023	dei	Entity File Number EntityFileNumber	001-33637
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37203
CY2023	dei	City Area Code CityAreaCode	615
CY2023	dei	Local Phone Number LocalPhoneNumber	255-0068
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.00 par value per share
CY2023	dei	Trading Symbol TradingSymbol	CPIX
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6453566	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7585019	usd
CY2023Q4	us-gaap	Liabilities Liabilities	52516206	usd
CY2022Q4	us-gaap	Liabilities Liabilities	56951152	usd
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Public Float EntityPublicFloat	12061328	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14176529	shares
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3300000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	213
CY2022	dei	Auditor Firm AuditorFirmId	686
CY2023	dei	Auditor Name AuditorName	Carr, Riggs & Ingram, LLC
CY2023	dei	Auditor Location AuditorLocation	Nashville, Tennessee
CY2022	dei	Auditor Name AuditorName	FORVIS, LLP
CY2022	dei	Auditor Location AuditorLocation	Nashville, Tennessee
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18321624	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19757970	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9758176	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13163681	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4609362	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9863581	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3025248	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3084978	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	35714410	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	45870210	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	12804529	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7527167	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	367903	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	284039	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22607918	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30590678	usd
CY2023Q4	us-gaap	Goodwill Goodwill	914000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	914000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6674394	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5218403	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2692921	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2520661	usd
CY2023Q4	us-gaap	Assets Assets	81776075	usd
CY2022Q4	us-gaap	Assets Assets	92925158	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14037629	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10819011	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	348092	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	172910	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13596528	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17587911	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27982249	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28579832	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	12784144	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	16200000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5296247	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4586301	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14121833	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14121833	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14366316	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14366316	shares
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47091602	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47474973	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17488161	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11208841	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	29603441	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	36266132	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-343572	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-292126	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29259869	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35974006	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81776075	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92925158	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39552507	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42010949	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6066611	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9118521	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18451765	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16660945	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5834229	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6688924	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10651915	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10180120	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8102648	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5067368	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	49107168	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	47715878	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-9554661	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5704929	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	286854	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	98405	usd
CY2022	us-gaap	Other Income OtherIncome	0	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	475000	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	585995	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-51446	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6279320	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5570241	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14298774	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14563592	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14298774	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14563592	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-6330766	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5650039	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4935954	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5328113	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3343842	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	834500	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-20256	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	365040	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	447503	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1253840	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2088296	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	15523	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	11237	usd
CY2023	cpix	Noncash Or Part Noncash Gain On Transaction NoncashOrPartNoncashGainOnTransaction	0	usd
CY2022	cpix	Noncash Or Part Noncash Gain On Transaction NoncashOrPartNoncashGainOnTransaction	37882	usd
CY2023	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	346800	usd
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	611330	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3404949	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6115640	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23143	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-911078	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-65684	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-689260	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1405363	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3724174	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14536076	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1131453	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	419659	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6093821	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8453396	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	281268	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	102148	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	171783	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1971662	usd
CY2023	cpix	Proceeds From Collaborative Arrangement ProceedsFromCollaborativeArrangement	0	usd
CY2022	cpix	Proceeds From Collaborative Arrangement ProceedsFromCollaborativeArrangement	1000000	usd
CY2023	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	347356	usd
CY2022	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	877597	usd
CY2023	cpix	Proceeds From Settlement Of Patent Litigation ProceedsFromSettlementOfPatentLitigation	0	usd
CY2022	cpix	Proceeds From Settlement Of Patent Litigation ProceedsFromSettlementOfPatentLitigation	21757	usd
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	13500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-105695	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13674456	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	31475000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	52900000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	34890856	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	51700000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1053042	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	3268083	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2208744	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7424472	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2061786	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1436346	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7282846	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27040816	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18321624	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19757970	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	647137	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	523161	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	108823	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3300	usd
CY2023	cpix	Cash Payment Included In Measurement Of Lease Liability CashPaymentIncludedInMeasurementOfLeaseLiability	804818	usd
CY2022	cpix	Cash Payment Included In Measurement Of Lease Liability CashPaymentIncludedInMeasurementOfLeaseLiability	1011313	usd
CY2023	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-51895	usd
CY2022	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-1803403	usd
CY2023	cpix	Change In Unpaid Invoices For Offering Costs ChangeInUnpaidInvoicesForOfferingCosts	69001	usd
CY2022	cpix	Change In Unpaid Invoices For Offering Costs ChangeInUnpaidInvoicesForOfferingCosts	-94689	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1158367	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4590978	usd
CY2023	cpix	Credit Issued For Milestone Payable CreditIssuedForMilestonePayable	0	usd
CY2022	cpix	Credit Issued For Milestone Payable CreditIssuedForMilestonePayable	-1000000	usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	0	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	399600	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5650039	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	399600	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	447503	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1025836	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35974006	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-6330766	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	365040	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	748411	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29259869	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-51446	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79798	usd
CY2019	cpix	Sharebased Compensation Charitable Contributionof Shares Shares SharebasedCompensationCharitableContributionofSharesShares	50000	shares
CY2023	cpix	Share Based Compensation Charitable Contribution Of Shares Cash Contributions ShareBasedCompensationCharitableContributionOfSharesCashContributions	40000	usd
CY2022	cpix	Share Based Compensation Charitable Contribution Of Shares Cash Contributions ShareBasedCompensationCharitableContributionOfSharesCashContributions	25000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company’s most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory, (3) valuation of contingent consideration liability associated with business combinations and (4) evaluation of continuing utility of intangible assets.</span></div>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q1	cpix	Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities	100000000	usd
CY2021Q4	cpix	Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities	19000000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3300000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	2903741	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3300000	usd
CY2023	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	881829	usd
CY2022	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	857842	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2927041	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	12804529	usd
CY2023Q2	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	1000000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	500000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12619092	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12899659	usd
CY2023Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	149701	usd
CY2022Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	168923	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4645098	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4322167	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	17413891	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	17390748	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	12804529	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7527167	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4609362	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9863581	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7527167	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	500000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2605976	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2369224	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2238073	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2085185	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	367903	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	284039	usd
CY2023	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	177148	usd
CY2022	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	260745	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22607918	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30590678	usd
CY2023Q4	us-gaap	Goodwill Goodwill	914000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	914000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8102648	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5067368	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4304157	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4245825	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3859206	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3452780	usd
CY2023Q4	cpix	Finite Lived Intangible Assets Amortization Expense Year Four And After FiniteLivedIntangibleAssetsAmortizationExpenseYearFourAndAfter	6745950	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22607918	usd
CY2023Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	7579783	usd
CY2022Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	8347214	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1197832	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1440859	usd
CY2023Q4	cpix	Accrued Liabilities Stock Payable AccruedLiabilitiesStockPayable	827813	usd
CY2022Q4	cpix	Accrued Liabilities Stock Payable AccruedLiabilitiesStockPayable	2226725	usd
CY2023Q4	cpix	Business Combination Contingent Consideration Liability Accrued Current BusinessCombinationContingentConsiderationLiabilityAccruedCurrent	2424000	usd
CY2022Q4	cpix	Business Combination Contingent Consideration Liability Accrued Current BusinessCombinationContingentConsiderationLiabilityAccruedCurrent	3006310	usd
CY2023Q4	cpix	Accrued Liabilities Studies AccruedLiabilitiesStudies	385266	usd
CY2022Q4	cpix	Accrued Liabilities Studies AccruedLiabilitiesStudies	400702	usd
CY2023Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	0	usd
CY2022Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	609621	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	220402	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	614551	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	961432	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	941929	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13596528	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17587911	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3284672	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4931513	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2894894	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2522506	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	274000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	131000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6453566	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7585019	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	3000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-6330766	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5650039	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-51446	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79798	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6279320	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5570241	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14298774	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14563592	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14298774	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14563592	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	452224	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	227050	shares
CY2023Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	15427801	usd
CY2022Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	16164754	usd
CY2023Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	71990	usd
CY2022Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	264653	usd
CY2023Q4	cpix	Deferred Tax Asset Operating Lease Liabilities DeferredTaxAssetOperatingLeaseLiabilities	1307178	usd
CY2022Q4	cpix	Deferred Tax Asset Operating Lease Liabilities DeferredTaxAssetOperatingLeaseLiabilities	1121800	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2337091	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	866942	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2208093	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1481455	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	147919	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	145803	usd
CY2023Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	616979	usd
CY2022Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	654148	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	185189	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	217025	usd
CY2023Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	937935	usd
CY2022Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	1156150	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	176926	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	635989	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	23417101	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22708719	usd
CY2023Q4	cpix	Deferred Tax Liability Operating Lease Right Of Use Assets DeferredTaxLiabilityOperatingLeaseRightOfUseAssets	1547773	usd
CY2022Q4	cpix	Deferred Tax Liability Operating Lease Right Of Use Assets DeferredTaxLiabilityOperatingLeaseRightOfUseAssets	1150935	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	usd
CY2023Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	21869328	usd
CY2022Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	21557784	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21869328	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21557784	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	45769	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	68850	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	45769	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	68850	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45769	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68850	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0058
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0211
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.0080
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0496
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2176
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.0651
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.0258
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0332
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0
CY2023	cpix	Effective Income Tax Rate Reconciliation Deferred True Ups Percent EffectiveIncomeTaxRateReconciliationDeferredTrueUpsPercent	-0.0716
CY2022	cpix	Effective Income Tax Rate Reconciliation Deferred True Ups Percent EffectiveIncomeTaxRateReconciliationDeferredTrueUpsPercent	0
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0073
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0123
CY2023	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Available For Future Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants	2	plan
CY2023	cpix	Share Based Compensation Arrangement By Share Based Payment Award Shareholder Percent ShareBasedCompensationArrangementByShareBasedPaymentAwardShareholderPercent	0.10
CY2023	cpix	Share Based Compensation Arrangement By Share Based Payment Award Shareholder Percent ShareBasedCompensationArrangementByShareBasedPaymentAwardShareholderPercent	0.10
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	500000	usd
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	170600	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.33
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	178950	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.68
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	29900	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.98
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	319650	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.00
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	192750	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.06
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	25150	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.55
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	487250	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.65
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M2D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.16
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.29
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
CY2023	cpix	Defined Contribution Plan Eligibility Minimum Employee Age DefinedContributionPlanEligibilityMinimumEmployeeAge	P21Y
CY2023	cpix	Defined Contribution Plan Eligibility Minimum Employee Service Time For Participation Eligibility DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility	P6M
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	80000.00	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	60000.00	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	2900000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	2500000	usd
CY2023Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	2400000	usd
CY2022Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	2300000	usd
CY2021Q4	cpix	Lessee Operating Lease Rent Increase LesseeOperatingLeaseRentIncrease	0.025
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1304865	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1159695	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	544138	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	529411	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6674394	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5218403	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	348092	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10888877	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10085926	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9353066	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39552507	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1531678	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	22859	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1866603	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-6179239	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	172910	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5296247	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4586301	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5644339	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4759211	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	300000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	863320	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	836100	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	909911	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	934180	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	740791	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4847400	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9131702	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3487363	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5644339	usd
CY2023Q2	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	1000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9224638	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-9554661	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	172286	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	862154	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1063219	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-6301987	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-6330766	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	192184	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	872200	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1049298	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6294406	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6279320	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11175045	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10299152	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11413072	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9123680	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42010949	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1291999	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1846538	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-288588	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2277804	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5704929	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1402433	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1364666	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-423226	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-2459714	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5650039	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1385253	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1335620	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-408639	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2440729	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5570241	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.38
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.17
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.38

Files In Submission

Name	View Source	Status
0001628280-24-010725-index-headers.html	Edgar Link	pending
0001628280-24-010725-index.html	Edgar Link	pending
0001628280-24-010725.txt	Edgar Link	pending
0001628280-24-010725-xbrl.zip	Edgar Link	pending
a2023-10kxex231consentofcri.htm	Edgar Link	pending
a2023-10kxexhibit311.htm	Edgar Link	pending
a2023-10kxexhibit312.htm	Edgar Link	pending
a2023-10kxexhibit321.htm	Edgar Link	pending
a2023-xex232consentofforvi.htm	Edgar Link	pending
a2023-xex971compensationre.htm	Edgar Link	pending
a2023q4exhibit411.htm	Edgar Link	pending
cpix-20231231.htm	Edgar Link	pending
cpix-20231231.xsd	Edgar Link	pending
cpix-20231231_g1.jpg	Edgar Link	pending
ex-1011ajkazimix202310k.htm	Edgar Link	pending
ex-1012jimhermanx202310k.htm	Edgar Link	pending
ex-1013toddanthonyx202310k.htm	Edgar Link	pending
ex-1014chrisbittermanx2023.htm	Edgar Link	pending
ex-1015johnhammx202310k.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cpix-20231231_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cpix-20231231_cal.xml	Edgar Link	unprocessable
cpix-20231231_def.xml	Edgar Link	unprocessable
cpix-20231231_lab.xml	Edgar Link	unprocessable
cpix-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2024 Q1 Form 10-K Financial Statement

#000162828024010725 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2024 Q1 Form 10-K Financial Statement

#000162828024010725 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix